Kite Pharma, Inc.
Kite Pharma, Inc. (KITE) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 656 transactions totaling $204.8M, demonstrating a bearish sentiment with -$193.2M in net insider flow. The most recent transaction on Oct 3, 2017 involved a transaction of 159,329 shares valued at $28.7M.
KITE Insider Activity Summary
Who Is Buying KITE Stock?
No significant insider buying has been recorded for KITE in the recent period.
Who Is Selling KITE Stock?
No significant insider selling has been recorded for KITE in the recent period.
Is Kite Pharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KITE is bearish with an Insider Alignment Score of 3/100 and a net flow of -$193.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
KITE Frequently Asked Questions
Understanding KITE Insider Activity
Insider trading at Kite Pharma, Inc. (KITE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading KITE stock, having executed 656 transactions in the past 90 days. The most active insider is Arie Belldegrun (Executive), who has made 22 transactions totaling $581.6M.
Related Tools
Track Kite Pharma, Inc. Insider Activity
Get notified when executives and directors at KITE file new Form 4 transactions